Microneedle drug delivery systems usually include Hollow Microneedle Technology microneedle and Dissolving Microneedles Technology microneedle technology, offer patient-friendly delivery solutions for vaccines or difficult-to-deliver biologics for particularly needle-phobic patients.
In this report, we mainly study the forecast market due to there is no product on the market, most product on the research.
麻豆原创 Analysis and Insights: Global Microneedle Drug Delivery Systems 麻豆原创
The global Microneedle Drug Delivery Systems market is projected to grow from US$ 7 million in 2024 to US$ 205.1 million by 2030, at a Compound Annual Growth Rate (CAGR) of 75.0% during the forecast period.
Microneedles are a rapidly growing technology developed to solve issues surrounding intradermal drug administration. While many microneedle platforms have been developed over nearly 2 decades, the issues and concerns remain largely the same.
The classification of Microneedle Drug Delivery Systems includes Hollow Microneedle Technology, Solid Microneedle Technology and Dissolving Microneedles Technology, and the proportion of Hollow Microneedle Technology occupies the most proportions.
Microneedle Drug Delivery Systems is widely used in Drug Delivery, Vaccine Delivery and other field. The most proportion of Microneedle Drug Delivery Systems is used for vaccine delivery.
3M, Zosano Pharma, Becton-Dickinson(BD)Technologies, Nanopass Technologies, Corium, Valeritas are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
Report Covers:
This report presents an overview of global market for Microneedle Drug Delivery Systems market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Microneedle Drug Delivery Systems, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Microneedle Drug Delivery Systems, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Microneedle Drug Delivery Systems revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Microneedle Drug Delivery Systems market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Microneedle Drug Delivery Systems revenue, projected growth trends, production technology, application and end-user industry.
麻豆原创 Segmentation
By Company
KINDEVA
Zosano Pharma
Becton-Dickinson(BD)Technologies
Nanopass Technologies
Corium
Valeritas
Nitto
Microdermics
TheraJect, Inc
Vaxxas
Lohmann Therapie-Systeme AG
Segment by Type
Hollow Microneedle Technology
Solid Microneedle Technology
Dissolving Microneedles Technology
Segment by Application
Drug Delivery
Vaccine Delivery
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Microneedle Drug Delivery Systems in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Microneedle Drug Delivery Systems companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Microneedle Drug Delivery Systems revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Microneedle Drug Delivery Systems 麻豆原创 Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Hollow Microneedle Technology
1.2.3 Solid Microneedle Technology
1.2.4 Dissolving Microneedles Technology
1.3 麻豆原创 by Application
1.3.1 Global Microneedle Drug Delivery Systems 麻豆原创 Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Drug Delivery
1.3.3 Vaccine Delivery
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Microneedle Drug Delivery Systems 麻豆原创 Perspective (2019-2030)
2.2 Global Microneedle Drug Delivery Systems Growth Trends by Region
2.2.1 Microneedle Drug Delivery Systems 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Microneedle Drug Delivery Systems Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Microneedle Drug Delivery Systems Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Microneedle Drug Delivery Systems 麻豆原创 Dynamics
2.3.1 Microneedle Drug Delivery Systems Industry Trends
2.3.2 Microneedle Drug Delivery Systems 麻豆原创 Drivers
2.3.3 Microneedle Drug Delivery Systems 麻豆原创 Challenges
2.3.4 Microneedle Drug Delivery Systems 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Microneedle Drug Delivery Systems by Players
3.1.1 Global Microneedle Drug Delivery Systems Revenue by Players (2019-2024)
3.1.2 Global Microneedle Drug Delivery Systems Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Microneedle Drug Delivery Systems 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Microneedle Drug Delivery Systems, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Microneedle Drug Delivery Systems 麻豆原创 Concentration Ratio
3.4.1 Global Microneedle Drug Delivery Systems 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Microneedle Drug Delivery Systems Revenue in 2023
3.5 Global Key Players of Microneedle Drug Delivery Systems Head office and Area Served
3.6 Global Key Players of Microneedle Drug Delivery Systems, Product and Application
3.7 Global Key Players of Microneedle Drug Delivery Systems, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Microneedle Drug Delivery Systems Breakdown Data by Type
4.1 Global Microneedle Drug Delivery Systems Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Microneedle Drug Delivery Systems Forecasted 麻豆原创 Size by Type (2025-2030)
5 Microneedle Drug Delivery Systems Breakdown Data by Application
5.1 Global Microneedle Drug Delivery Systems Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Microneedle Drug Delivery Systems Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Microneedle Drug Delivery Systems 麻豆原创 Size (2019-2030)
6.2 North America Microneedle Drug Delivery Systems 麻豆原创 Size by Type
6.2.1 North America Microneedle Drug Delivery Systems 麻豆原创 Size by Type (2019-2024)
6.2.2 North America Microneedle Drug Delivery Systems 麻豆原创 Size by Type (2025-2030)
6.2.3 North America Microneedle Drug Delivery Systems 麻豆原创 Share by Type (2019-2030)
6.3 North America Microneedle Drug Delivery Systems 麻豆原创 Size by Application
6.3.1 North America Microneedle Drug Delivery Systems 麻豆原创 Size by Application (2019-2024)
6.3.2 North America Microneedle Drug Delivery Systems 麻豆原创 Size by Application (2025-2030)
6.3.3 North America Microneedle Drug Delivery Systems 麻豆原创 Share by Application (2019-2030)
6.4 North America Microneedle Drug Delivery Systems 麻豆原创 Size by Country
6.4.1 North America Microneedle Drug Delivery Systems 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Microneedle Drug Delivery Systems 麻豆原创 Size by Country (2019-2024)
6.4.3 North America Microneedle Drug Delivery Systems 麻豆原创 Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Microneedle Drug Delivery Systems 麻豆原创 Size (2019-2030)
7.2 Europe Microneedle Drug Delivery Systems 麻豆原创 Size by Type
7.2.1 Europe Microneedle Drug Delivery Systems 麻豆原创 Size by Type (2019-2024)
7.2.2 Europe Microneedle Drug Delivery Systems 麻豆原创 Size by Type (2025-2030)
7.2.3 Europe Microneedle Drug Delivery Systems 麻豆原创 Share by Type (2019-2030)
7.3 Europe Microneedle Drug Delivery Systems 麻豆原创 Size by Application
7.3.1 Europe Microneedle Drug Delivery Systems 麻豆原创 Size by Application (2019-2024)
7.3.2 Europe Microneedle Drug Delivery Systems 麻豆原创 Size by Application (2025-2030)
7.3.3 Europe Microneedle Drug Delivery Systems 麻豆原创 Share by Application (2019-2030)
7.4 Europe Microneedle Drug Delivery Systems 麻豆原创 Size by Country
7.4.1 Europe Microneedle Drug Delivery Systems 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Microneedle Drug Delivery Systems 麻豆原创 Size by Country (2019-2024)
7.4.3 Europe Microneedle Drug Delivery Systems 麻豆原创 Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Microneedle Drug Delivery Systems 麻豆原创 Size (2019-2030)
8.2 China Microneedle Drug Delivery Systems 麻豆原创 Size by Type
8.2.1 China Microneedle Drug Delivery Systems 麻豆原创 Size by Type (2019-2024)
8.2.2 China Microneedle Drug Delivery Systems 麻豆原创 Size by Type (2025-2030)
8.2.3 China Microneedle Drug Delivery Systems 麻豆原创 Share by Type (2019-2030)
8.3 China Microneedle Drug Delivery Systems 麻豆原创 Size by Application
8.3.1 China Microneedle Drug Delivery Systems 麻豆原创 Size by Application (2019-2024)
8.3.2 China Microneedle Drug Delivery Systems 麻豆原创 Size by Application (2025-2030)
8.3.3 China Microneedle Drug Delivery Systems 麻豆原创 Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Microneedle Drug Delivery Systems 麻豆原创 Size (2019-2030)
9.2 Asia Microneedle Drug Delivery Systems 麻豆原创 Size by Type
9.2.1 Asia Microneedle Drug Delivery Systems 麻豆原创 Size by Type (2019-2024)
9.2.2 Asia Microneedle Drug Delivery Systems 麻豆原创 Size by Type (2025-2030)
9.2.3 Asia Microneedle Drug Delivery Systems 麻豆原创 Share by Type (2019-2030)
9.3 Asia Microneedle Drug Delivery Systems 麻豆原创 Size by Application
9.3.1 Asia Microneedle Drug Delivery Systems 麻豆原创 Size by Application (2019-2024)
9.3.2 Asia Microneedle Drug Delivery Systems 麻豆原创 Size by Application (2025-2030)
9.3.3 Asia Microneedle Drug Delivery Systems 麻豆原创 Share by Application (2019-2030)
9.4 Asia Microneedle Drug Delivery Systems 麻豆原创 Size by Region
9.4.1 Asia Microneedle Drug Delivery Systems 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Microneedle Drug Delivery Systems 麻豆原创 Size by Region (2019-2024)
9.4.3 Asia Microneedle Drug Delivery Systems 麻豆原创 Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Microneedle Drug Delivery Systems 麻豆原创 Size (2019-2030)
10.2 Middle East, Africa, and Latin America Microneedle Drug Delivery Systems 麻豆原创 Size by Type
10.2.1 Middle East, Africa, and Latin America Microneedle Drug Delivery Systems 麻豆原创 Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Microneedle Drug Delivery Systems 麻豆原创 Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Microneedle Drug Delivery Systems 麻豆原创 Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Microneedle Drug Delivery Systems 麻豆原创 Size by Application
10.3.1 Middle East, Africa, and Latin America Microneedle Drug Delivery Systems 麻豆原创 Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Microneedle Drug Delivery Systems 麻豆原创 Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Microneedle Drug Delivery Systems 麻豆原创 Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Microneedle Drug Delivery Systems 麻豆原创 Size by Country
10.4.1 Middle East, Africa, and Latin America Microneedle Drug Delivery Systems 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Microneedle Drug Delivery Systems 麻豆原创 Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Microneedle Drug Delivery Systems 麻豆原创 Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 KINDEVA
11.1.1 KINDEVA Company Details
11.1.2 KINDEVA Business Overview
11.1.3 KINDEVA Microneedle Drug Delivery Systems Introduction
11.1.4 KINDEVA Revenue in Microneedle Drug Delivery Systems Business (2019-2024)
11.1.5 KINDEVA Recent Developments
11.2 Zosano Pharma
11.2.1 Zosano Pharma Company Details
11.2.2 Zosano Pharma Business Overview
11.2.3 Zosano Pharma Microneedle Drug Delivery Systems Introduction
11.2.4 Zosano Pharma Revenue in Microneedle Drug Delivery Systems Business (2019-2024)
11.2.5 Zosano Pharma Recent Developments
11.3 Becton-Dickinson(BD)Technologies
11.3.1 Becton-Dickinson(BD)Technologies Company Details
11.3.2 Becton-Dickinson(BD)Technologies Business Overview
11.3.3 Becton-Dickinson(BD)Technologies Microneedle Drug Delivery Systems Introduction
11.3.4 Becton-Dickinson(BD)Technologies Revenue in Microneedle Drug Delivery Systems Business (2019-2024)
11.3.5 Becton-Dickinson(BD)Technologies Recent Developments
11.4 Nanopass Technologies
11.4.1 Nanopass Technologies Company Details
11.4.2 Nanopass Technologies Business Overview
11.4.3 Nanopass Technologies Microneedle Drug Delivery Systems Introduction
11.4.4 Nanopass Technologies Revenue in Microneedle Drug Delivery Systems Business (2019-2024)
11.4.5 Nanopass Technologies Recent Developments
11.5 Corium
11.5.1 Corium Company Details
11.5.2 Corium Business Overview
11.5.3 Corium Microneedle Drug Delivery Systems Introduction
11.5.4 Corium Revenue in Microneedle Drug Delivery Systems Business (2019-2024)
11.5.5 Corium Recent Developments
11.6 Valeritas
11.6.1 Valeritas Company Details
11.6.2 Valeritas Business Overview
11.6.3 Valeritas Microneedle Drug Delivery Systems Introduction
11.6.4 Valeritas Revenue in Microneedle Drug Delivery Systems Business (2019-2024)
11.6.5 Valeritas Recent Developments
11.7 Nitto
11.7.1 Nitto Company Details
11.7.2 Nitto Business Overview
11.7.3 Nitto Microneedle Drug Delivery Systems Introduction
11.7.4 Nitto Revenue in Microneedle Drug Delivery Systems Business (2019-2024)
11.7.5 Nitto Recent Developments
11.8 Microdermics
11.8.1 Microdermics Company Details
11.8.2 Microdermics Business Overview
11.8.3 Microdermics Microneedle Drug Delivery Systems Introduction
11.8.4 Microdermics Revenue in Microneedle Drug Delivery Systems Business (2019-2024)
11.8.5 Microdermics Recent Developments
11.9 TheraJect, Inc
11.9.1 TheraJect, Inc Company Details
11.9.2 TheraJect, Inc Business Overview
11.9.3 TheraJect, Inc Microneedle Drug Delivery Systems Introduction
11.9.4 TheraJect, Inc Revenue in Microneedle Drug Delivery Systems Business (2019-2024)
11.9.5 TheraJect, Inc Recent Developments
11.10 Vaxxas
11.10.1 Vaxxas Company Details
11.10.2 Vaxxas Business Overview
11.10.3 Vaxxas Microneedle Drug Delivery Systems Introduction
11.10.4 Vaxxas Revenue in Microneedle Drug Delivery Systems Business (2019-2024)
11.10.5 Vaxxas Recent Developments
11.11 Lohmann Therapie-Systeme AG
11.11.1 Lohmann Therapie-Systeme AG Company Details
11.11.2 Lohmann Therapie-Systeme AG Business Overview
11.11.3 Lohmann Therapie-Systeme AG Microneedle Drug Delivery Systems Introduction
11.11.4 Lohmann Therapie-Systeme AG Revenue in Microneedle Drug Delivery Systems Business (2019-2024)
11.11.5 Lohmann Therapie-Systeme AG Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
KINDEVA
Zosano Pharma
Becton-Dickinson(BD)Technologies
Nanopass Technologies
Corium
Valeritas
Nitto
Microdermics
TheraJect, Inc
Vaxxas
Lohmann Therapie-Systeme AG
听
听
*If Applicable.
